Your browser doesn't support javascript.
loading
Efficacy and safety of gemigliptin as add-on therapy to insulin, with or without metformin, in patients with type 2 diabetes mellitus (ZEUS II study).
Cho, Young Min; Deerochanawong, Chaicharn; Seekaew, Samroeng; Suraamornkul, Swangjit; Benjachareonwong, Sunun; Sattanon, Sarinya; Chamnan, Parinya; Sirirak, Thanitha; Kosachunhanun, Natapong; Pratipanawatr, Thongchai; Suwanwalaikorn, Sompongse; Lee, Woo Je; Kim, Sungrae; Choi, Seonghui; Kang, Eun Seok; Oh, Taekeun; Kwon, Sam; Lee, Moon-Kyu.
Afiliación
  • Cho YM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
  • Deerochanawong C; Diabetes and Endocrinology Unit, Rajavithi Hospital, Rangsit University College of Medicine, Bangkok, Thailand.
  • Seekaew S; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
  • Suraamornkul S; Vajira Hospital, Faculty of Medicine, Navamindradhiraj University, Bangkok, Thailand.
  • Benjachareonwong S; Police General Hospital, Bangkok, Thailand.
  • Sattanon S; Naresuan University Hospital, Phitsanulok, Thailand.
  • Chamnan P; Cardiometabolic Research Group, Department of Social Medicine, Sanpasitthiprasong Hospital, Ubon Ratchathani, Thailand.
  • Sirirak T; Department of Family Medicine and Preventive Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
  • Kosachunhanun N; Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand.
  • Pratipanawatr T; Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
  • Suwanwalaikorn S; Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Lee WJ; Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, South Korea.
  • Kim S; Division of Endocrinology and Metabolism, Catholic University of Korea, Seoul, South Korea.
  • Choi S; Department of Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Kang ES; Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Oh T; Chungbuk National University Hospital, Chungbuk National University College of Medicine, Chungbuk, Cheongju, South Korea.
  • Kwon S; Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, South Korea.
  • Lee MK; Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Diabetes Obes Metab ; 22(1): 123-127, 2020 01.
Article en En | MEDLINE | ID: mdl-31478335
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piperidonas / Pirimidinas / Diabetes Mellitus Tipo 2 / Insulina / Metformina Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2020 Tipo del documento: Article País de afiliación: Corea del Sur
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piperidonas / Pirimidinas / Diabetes Mellitus Tipo 2 / Insulina / Metformina Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2020 Tipo del documento: Article País de afiliación: Corea del Sur